Nova Hub
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR OOI KENG THYE
NOVA MSC BERHAD 26 January 2026 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 22 Jan 2026 320,000 Acquired Direct Interest Name of registered holder Ooi Keng Thye Description of “Others” Type…
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR OOI KENG THYE
NOVA MSC BERHAD 22 January 2026 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 20 Jan 2026 2,323,400 Acquired Direct Interest Name of registered holder Ooi Keng Thye Description of “Others” Type…
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR OOI KENG THYE
NOVA MSC BERHAD 20 January 2026 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 16 Jan 2026 500,000 Acquired Direct Interest Name of registered holder Ooi Keng Thye Description of “Others” Type…
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016) – MR OOI KENG THYE
NOVA MSC BERHAD 12 January 2026 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 08 Jan 2026 1,000,000 Acquired Direct Interest Name of registered holder Ooi Keng Thye Description of “Others” Type of…
CO-FOUNDERS OF EyRIS RECOGNISED AMONG THE WORLD’S TOP OPHTHALMOLOGY SCHOLARS
5 Jan 2026 – EyRIS is proud to announce that our co-founders, Associate Professor Daniel Ting Director of SingHealth AI Office and Head of AI and Digital Innovation in Singapore Eye Research Institute (SERI) , and Professor Wong Tien Yin Senior Vice-Chancellor of Tsinghua Medicine and Vice-Provost of Tsinghua University, China have been recognised by ScholarGPS as the 2nd &…
ISLAND HOSPITAL, PENANG AWARDED FLAGSHIP MEDICAL TOURISM HOSPITAL FOR 2025
17 December 2025 – Over the years, Malaysia has seen robust growth in health tourism. This year the industry projected to welcome about 1.6 million healthcare travelers in 2025, generating RM2.72 billion (USD666 million) in revenue. Malaysia Healthcare Travel Council (MHTC), the lead agency tasked to promote Malaysia’s healthcare tourism declared Island Hospital (IH), Penang the winner of the Flagship…
CELEBRATING EXCELLENCE IN QUALITY & COMPLIANCE
4 December 2025 – We pleased to announce that EyRIS has successfully completed ISO 13485 recertification and the European MDR audit with zero non-compliance. This achievement demonstrates continuous commitment to the highest quality and regulatory standards in the medical device industry. Key highlights: Among the first companies in Singapore to secure HSA approval for an AI software as a medical…
OTHERS
NOVA MSC BERHAD 03 December 2025 The Board of Directors of NovaMSC (“Board”) wishes to announce that the Company’s external auditors, Messrs. LTTH PLT has retired at the conclusion of the 23rd Annual General Meeting of the Company held earlier today. The Company will appoint new external auditors and the relevant announcement will be made in due course. This announcement…
GENERAL MEETINGS: Outcome of Meeting
NOVA MSC BERHAD 03 December 2025 Type of Meeting General Indicator Outcome of Meeting Date of Meeting 03 Dec 2025 Time 09:30 AM Venue(s) Tropicana Golf & Country Resort, Jalan Kelab Tropicana, 47410 Petaling Jaya, Selangor Darul Ehsan, Malaysia Outcome of Meeting Nova MSC Berhad (“Company”) wishes to inform that at the 23rd Annual General Meeting (“23rd AGM”) of the Company held on Wednesday, 03…
OTHERS NOVA MSC BERHAD (“NOVAMSC” OR THE “COMPANY”) Dex-lab Pte Ltd, a subsidiary of NOVAMSC, appoints Sponsor for SGX Listing
NOVA MSC BERHAD 01 December 2025 1. INTRODUCTION The Board of Directors of the Company (“the Board”) wishes to announce that Dex-lab Pte Ltd (“Dex-lab”), a subsidiary of the Company, has appointed Evolve Capital Advisory Private Limited as the sponsor for Dex-lab’s proposed listing on the Catalist Board of the Singapore Exchange Securities Trading Limited (“SGX”). 2. DETAILS…
Quarterly rpt on consolidated results for the financial period ended 30 Sep 2025
NOVA MSC BERHAD 20 November 2025 Financial Year End 30 Jun 2025 Quarter 1 Qtr Quarterly report for the financial period ended 30 Sep 2025 The figures have not been audited NMSC_report_FY2526_1Qtr_final.pdf
OTHERS NOVA MSC BERHAD (“NOVAMSC” OR “COMPANY”) Deviation of 10% or More Between the Unaudited and Audited financial Statement for the Financial Period Ended 30 June 2025
NOVA MSC BERHAD 11 November 2025 Type Announcement Subject OTHERS Description NOVA MSC BERHAD (“NOVAMSC” OR “COMPANY”) Deviation of 10% or More Between the Unaudited and Audited financial Statement for the Financial Period Ended 30 June 2025 Pursuant to Rule 9.19(36) of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad (“Bursa Securities”), the Board of Directors…